Large-scale testing (Phase 3)Study completedNCT03969901
What this trial is testing
Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021)
Who this might be right for
Suspected or Documented Gram-negative Bacterial Infection
Merck Sharp & Dohme LLC 115